The direct binding of quercetin to BCL-2 family proteins can trigger pro-apoptotic activity, which is particularly relevant given that anti-apoptotic BCL-2 members are often overexpressed in various cancers, making them attractive therapeutic targets [32]. The gene discussed is BCL2; the disease is cancer.